C8> CONCORD DRUGS LIMITED Regd. Office & Factory : Survey No. 249, Brahmanapally Village, Hayathnagar Mandal, R.R. Dist. - 501 511. (T.S) INDIA 
Admin Office : 3-11-451, L B Nagar, Hyderabad - 500074 
E-mail : concorddrugsitd@gmail.com Ph.No : +91 9052779505 Website : www.concorddrugs.in 
To, Date: 20.11.2025 
BSE Limited, 
Phiroze Jeejeebhoy Towers, 
Dalal St, Fort, Mumbai, 
Maharashtra 400001 
Sub: Outcome of Meeting of Board of Directors of Concord Drugs Limited in 
accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure 
Requirements) Regulations, 2015. 
Dear Sir/Madam(s), 
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 
Regulations, 2015, we wish to inform you that the Board of Directors of our Company, 
in their meeting held today i.e., Thursday, 20t November,2025, inter alia, considered 
and approved the following business: 
1. Allotment of Equity Shares on Preferential Basis 
The Board considered and approved the allotment of 31,75,000 (Thirty-One Lakhs 
Seventy-Five Thousand) fully paid-up Equity Shares of face value ¥10/- each at an 
issue price of ¥36.30/- per share (including a premium of 326.30/-), aggregating to 
11,52,52,500/-, pursuant to the approval of the Shareholders at the Extraordinary 
General Meeting held on 31 July 2025, and in accordance with provisions of SEBI 
(Issue of Capital and Disclosure Requirements) Regulations 2018 
SLNo | Name of | Category | Maximum Shared Total 
Allottee number of | Allotted amount 
Shares to be received @ 
allotted Rs.36.30 per 
share 
1 S Nagi Reddy Promoter 2,00,000 2,00,000 72,60,000 
S Koni Reddy Promoter 1,50,000 1,50,000 54,45,000 
3 S Manoj Promoter 1,50,000 1,50,000 54,45,000 
Kumar Reddy 
4 Anjana Public 3,00,000 3,00,000 108,90,000 
bangad 
5 Anuradha Public 3,00,000 3,00,000 108,90,000 
bangad 
6 Pranali Public 3,00,000 3,00,000 108,90,000 
bangad 
7 Vikas bangad Public 3,00,000 3,00,000 108,90,000 
8 c sushmitha Public 11,00,000 11,00,000 399,30,000 
9 komal sharma Public 2,00,000 2,00,000 72,60,000 
1|Page
10 Mohan Public 50,000 50,000 18,15,000 
Thodupunuri 
11 Sharada Public 1,25,000 1,25,000 45,37,500 
Kovuri 
Total | 31,75,000 11,52,52,500 
2. Allotment of Convertible Warrants on Preferential Basis 
The Board considered and approved the allotment of 20,25,000 (Twenty Lakhs 
Twenty-Five Thousand) Convertible Warrants, each convertible into one (1) fully 
paid-up Equity Share of face value 310/ - each, at an issue price of 36.30 per warrant, 
aggregating to 37,35,07,500/ -. 
The Board recorded that the Company has received 25% upfront consideration for 
the warrants from each of the proposed allottees, through their respective bank 
accounts, in accordance with the SEBI (ICDR) Regulations. 
The warrants are convertible within 18 months from the date of allotment, in one or 
more tranches, subject to payment of the balance consideration. 
SL. No Name of Allottee(s) Category Maximum Warrants Received 
number of | allotted amount @ 
Warrants to 25% per 
be allotted warrant 
S. Nagi Reddy Promoter 7,00,000 7,00,000 63,52,500 
S. Koni Reddy Promoter 5,50,000 5,50,000 49,91,250 
S. Manoj Kumar Promoter 5,50,000 5,50,000 49,91,250 
Reddy 
4 Sheetal Sharma Public 2,25,000 2,25,000 20,41,875 
Total | 20,25,000 183,76,875 
The meeting commenced at 06:00 p.m. and concluded at 08:45 p.m. 
We request you to take the above information on record. 
Thanking you, 
Yours faithfully, 
For Concord Drugs Limited 
Seelam bty sgned by Seclmiiagi 
Nagi i 120 Reddy s <o 
S. Nagi Reddy 
Chairman & Managing Director 
DIN: 01764665 
2|Page 
